Aided by Yates and $3.7M in Biodefense Bucks, Diversa Wields Proteomics to Pin Down Targets | GenomeWeb

Microbial Biotech company Diversa has been using proteomics for several years. But in February 2003, its proteomics group got a boost when it was joined by about a dozen researchers — including John Yates — from the Torrey Mesa Research Institute, parts of which the San Diego-based company acquired from its partner Syngenta at the end of 2002.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.